ReviewBMC urology2023
Active surveillance should be considered for select men with Grade Group 2 prostate cancer.
Kelly R Pekala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewBMC urology2023
Kelly R Pekala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.